This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Ralf Kohler: Innovator in KCa3.1 Channel Activators
Introduction
Ralf Kohler is a notable inventor based in Zaragoza, Spain. He has made significant contributions to the field of biochemistry, particularly in the development of selective activators for the intermediate conductance calcium-activated potassium channel KCa3.1. His work has implications for therapeutic uses in both human and animal subjects.
Latest Patents
Ralf Kohler holds a patent for "Selective activators of the intermediate conductance CA2+activated K+ channel KCa3.1 and their methods of use." This patent includes benzoxazole and indole type KCa3.1 activators, as well as their therapeutic applications and uses in the ex vivo preservation of organs or tissues. He has 1 patent to his name, showcasing his innovative approach to medical science.
Career Highlights
Kohler is affiliated with the University of California, where he continues to advance research in his field. His work is characterized by a commitment to exploring new therapeutic avenues and enhancing the understanding of KCa3.1 channel functions.
Collaborations
Ralf Kohler has collaborated with esteemed colleagues such as Heike Wulff and Nichole Coleman. Their joint efforts contribute to the advancement of knowledge in the field of potassium channels and their therapeutic potential.
Conclusion
Ralf Kohler's innovative work in the realm of KCa3.1 channel activators highlights his dedication to scientific advancement. His contributions are paving the way for new therapeutic strategies in medicine.